P. Hans

12.0k total citations · 1 hit paper
279 papers, 8.7k citations indexed

About

P. Hans is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, P. Hans has authored 279 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Surgery, 65 papers in Molecular Biology and 44 papers in Epidemiology. Recurrent topics in P. Hans's work include Cholesterol and Lipid Metabolism (60 papers), Lipoproteins and Cardiovascular Health (52 papers) and Drug Transport and Resistance Mechanisms (35 papers). P. Hans is often cited by papers focused on Cholesterol and Lipid Metabolism (60 papers), Lipoproteins and Cardiovascular Health (52 papers) and Drug Transport and Resistance Mechanisms (35 papers). P. Hans collaborates with scholars based in Netherlands, Belgium and United States. P. Hans's co-authors include J. Wouter Jukema, Louis M. Havekes, Teake Kooistra, Vincent Bonhomme, Robert Kleemann, Lars Verschuren, Sabine M. Post, José W.A. van der Hoorn, Patrick C.N. Rensen and Wim van Duyvenvoorde and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

P. Hans

268 papers receiving 8.3k citations

Hit Papers

Systemic PFOS and PFOA exposure and disturbed lipid homeo... 2021 2026 2022 2024 2021 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
    2021 141 citations Styliani Fragki, Hubert Dirven et al. Critical Reviews in Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Hans Netherlands 53 3.2k 2.2k 1.4k 1.2k 1.0k 279 8.7k
Rodolfo Paoletti Italy 43 3.7k 1.1× 2.2k 1.0× 663 0.5× 1.1k 0.9× 827 0.8× 132 8.7k
Franco Cuccurullo Italy 52 1.8k 0.5× 1.5k 0.7× 734 0.5× 741 0.6× 960 1.0× 193 9.1k
Francisco Blanco‐Vaca Spain 41 2.3k 0.7× 1.5k 0.7× 639 0.5× 1.3k 1.1× 454 0.4× 178 5.5k
Francesco Cipollone Italy 50 1.5k 0.5× 1.6k 0.7× 904 0.6× 908 0.7× 1.1k 1.1× 194 8.1k
Seigo Sugiyama Japan 55 3.0k 0.9× 2.4k 1.1× 1.4k 1.0× 1.9k 1.5× 1.8k 1.8× 227 11.0k
Stefano Bellosta Italy 34 2.8k 0.9× 2.4k 1.1× 510 0.4× 706 0.6× 661 0.7× 94 7.3k
Y. Antero Kesäniemi Finland 48 3.7k 1.1× 1.9k 0.9× 2.0k 1.4× 3.7k 3.0× 677 0.7× 187 9.9k
Massimiliano Ruscica Italy 49 2.5k 0.8× 1.7k 0.8× 1.3k 0.9× 1.3k 1.0× 888 0.9× 226 7.0k
Christian M. Matter Switzerland 54 2.0k 0.6× 2.0k 0.9× 914 0.7× 573 0.5× 1.2k 1.2× 213 7.4k
Ulf Diczfalusy Sweden 61 6.9k 2.1× 5.0k 2.3× 853 0.6× 1.8k 1.4× 1.1k 1.1× 158 12.7k

Countries citing papers authored by P. Hans

Since Specialization
Citations

This map shows the geographic impact of P. Hans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hans more than expected).

Fields of papers citing papers by P. Hans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hans. The network helps show where P. Hans may publish in the future.

Co-authorship network of co-authors of P. Hans

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hans. A scholar is included among the top collaborators of P. Hans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hans. P. Hans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Martine C., Arianne van Koppen, Eveline Gart, et al.. (2025). Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH ‐Associated Fibrosis. The FASEB Journal. 39(12). e70735–e70735. 1 indexed citations
2.
Bar, Anna, Anna Kurpińska, Patrycja Kaczara, et al.. (2025). Effects of life-long hyperlipidaemia on age-dependent development of endothelial dysfunction in humanised dyslipidaemic mice. GeroScience. 47(3). 2673–2701.
3.
Attema, Joline, Aswin Menke, Martien P. M. Caspers, et al.. (2024). Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice. The FASEB Journal. 38(20). e70087–e70087. 3 indexed citations
4.
5.
Blom, Arjen B., Irene Di Ceglie, Birgitte Walgreen, et al.. (2023). Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice. Osteoarthritis and Cartilage. 31(7). 934–943. 3 indexed citations
6.
Stokman, Geurt, Martine C. Morrison, Lars Verschuren, et al.. (2023). Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 24(10). 8494–8494. 18 indexed citations
7.
Stokman, Geurt, Elsbet Pieterman, Martine C. Morrison, et al.. (2023). Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation. International Journal of Molecular Sciences. 24(9). 7818–7818. 12 indexed citations
8.
Carracedo, Miguel, Sven‐Christian Pawelzik, Gonzalo Artiach, et al.. (2022). The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. British Journal of Pharmacology. 179(19). 4709–4721. 9 indexed citations
9.
Pieterman, Elsbet, P. Hans, Magnus J. Johansson, et al.. (2021). Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs. European Journal of Pharmaceutical Sciences. 161. 105776–105776. 10 indexed citations
10.
Fragki, Styliani, Hubert Dirven, Tony Fletcher, et al.. (2021). Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?. Critical Reviews in Toxicology. 51(2). 141–164. 141 indexed citations breakdown →
11.
Stokman, Geurt, Anita M. van den Hoek, Elsbet Pieterman, et al.. (2020). Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. Liver International. 40(11). 2860–2876. 15 indexed citations
12.
Pouwer, Marianne, Valur Emilsson, Ljubica Matic, et al.. (2019). Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans. PLoS ONE. 14(8). e0221477–e0221477. 8 indexed citations
13.
Pouwer, Marianne, Suvi E. Heinonen, Margareta Behrendt, et al.. (2019). The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis. Journal of Diabetes Research. 2019. 1–13. 9 indexed citations
14.
Pouwer, Marianne, Elsbet Pieterman, Nanda Keijzer, et al.. (2019). Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice. Journal of Lipid Research. 61(3). 365–375. 52 indexed citations
15.
Pouwer, Marianne, Elsbet Pieterman, Shu‐Ching Chang, et al.. (2019). Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice. Toxicological Sciences. 168(2). 519–534. 27 indexed citations
16.
Pouwer, Marianne, Gerard Pasterkamp, Alain J. van Gool, et al.. (2018). Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice. PLoS ONE. 13(10). e0204911–e0204911. 17 indexed citations
17.
Post, Sabine M., Baukje de Roos, Lydia A. Afman, et al.. (1999). Cafestol, the cholesterol-raising factor in boiled coffee, increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Hepatology. 100(18). 3 indexed citations
18.
Kuipers, Folkert, et al.. (1995). Increased hepatic cholesterol synthesis in mdr2 P-glycoprotein deficient mice with impaired biliary cholesterol and phospholipid secretion. Circulation. 92(8). 494–494. 1 indexed citations
19.
Forte, Trudy M., Robert W. Nordhausen, & P. Hans. (1989). Structural properties of lipoproteins isolated from human primary hepatocyte cultures (abstract). Circulation. 80(5). 3 indexed citations
20.
Hans, P., et al.. (1987). EFFECTS OF CYCLOSPORINE A (CSA) ON LDL-RECEPTOR ACTIVITY AND BILE-ACID SYNTHESIS IN HEPATOCYTE MONOLAYER-CULTURES AND INVIVO IN RAT. Data Archiving and Networked Services (DANS). 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodolfo Paoletti Breakdown of academic impact, for papers by Franco Cuccurullo Breakdown of academic impact, for papers by Francisco Blanco‐Vaca Breakdown of academic impact, for papers by Francesco Cipollone Breakdown of academic impact, for papers by Seigo Sugiyama Breakdown of academic impact, for papers by Stefano Bellosta Breakdown of academic impact, for papers by Y. Antero Kesäniemi Breakdown of academic impact, for papers by Massimiliano Ruscica Breakdown of academic impact, for papers by Christian M. Matter Breakdown of academic impact, for papers by Ulf Diczfalusy
Rankless by CCL
2026